While the overexpression of METTL3, a key m6A methyltransferase, boosts sorafenib sensitivity in hepatocellular carcinoma by stabilizing FOXO3 mRNA via m6A methylation [43]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.